Explore More Than Just This Free Article

This article is a glimpse of the exclusive insights we provide daily to industry leaders. Dive deeper into our industry-specific reports and uncover the strategic information you need.

Azelis inaugurates its third Pharmaceuticals & Healthcare laboratory for the EMEA region in Courbevoie, France

March 28, 2023 (press release) –

Azelis, a leading innovation service provider in the specialty chemicals and food ingredients industry, is proud to announce the opening of a new Pharmaceuticals & Healthcare application laboratory in Courbevoie, France. Together with our pharmaceutical laboratories in the UK and Turkey, this new lab strengthens Azelis’ pharmaceutical presence in the EMEA region and enables the team to provide even more innovative and technical support to their customers.

This laboratory is fully equipped with all the necessary machinery for developing formulations, solving technical problems, and providing technical assistance. With Azelis' lateral value chain of APIs and excipients, the new application laboratory and its technical team can leverage their knowledge and expertise to combine various products, enhancing their properties and formulating innovative and sustainable solutions to solve the industry challenges for their customers.

The laboratory also focuses on answering customers’ concerns by creating innovative solutions in different areas such as: solubilization and bioavailability of APIs, improving compliance, combating counter-types and misuse, but also optimization of formulations and production processes.

Benoit Fritz, Managing Director of Azelis France, comments:

We are very proud to inaugurate this new Pharmaceuticals & Healthcare laboratory which complements our three laboratories dedicated to Food & Nutrition, Personal Care and Flavors & Fragrances. It strengthens our activity in Life Sciences in France but also in the EMEA region. This new state-of-the-art facility is where innovation comes to life. Azelis is a science-driven partner for customers and principals, consistently focused on innovating new, safe, and more sustainable solutions for the market.”

Matthew Dickman, Azelis Pharmaceuticals & Healthcare Market Segment Director EMEA, adds:

“We are thrilled to open this new Pharmaceuticals & Healthcare laboratory in France. Dedicated to dry forms, it will be perfectly complementary to the French Personal Care laboratory equipped for the development of liquid forms. This cross-fertilization, also effective at the regional level between the different centers of expertise of our pharmaceutical laboratories focused on dry-form, liquid, semi-solid and tablet coatings, enables our technical teams to create synergies and share best practices, formulations and know-how. We will work closely together with principals, customers, and our pharmaceutical team to bring new, innovative formulations to the market.”

 

 

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo with Jason
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order chemicals industry coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.